chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arms were aching a little bit and my hands/ just have a faultier and a slight ache in my hands and arms; I just don't feel good; Blood pressure went up; it was 166/90 and that's lit bit higher than usual days; This is a spontaneous report from contactable consumer (patient) reported for herself. A 78-years-old female patient received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 01Oct2021 (age at vaccination was 78 years) as dose 3 (booster), single for COVID-19 immunization. The patient's medical history included diabetes mellitus from unspecified date (the patient had diabetes it was under control, she checked her sugar it was 110). The patient's concomitant medications were not reported. The co-suspect medication included naproxen sodium (ALEVE) via an unspecified route of administration (Batch/Lot number: unknown) start and stop date were not reported, taken for an unspecified indication. The patient asked if it was okay to take Aleve, some type of pain medicine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 2, single for COVID-19 immunization and the patient didn't have any side effects from the first and second shot. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had her Pfizer COVID-19 Booster Shot on Friday (01Oct2021) and she felt fine until yesterday (02Oct2021) afternoon, Saturday afternoon. She had a side effect or reaction to it. On 02Oct2021, the patient experienced her arms were aching a little bit and her hands and she just didn't feel good and her blood pressure went up, it was 166/90 and that was lit bit higher than usual days. She had slight ache in her hands and arms on the right side. She wanted to know if those were side effects from the booster shot or something else but she just had a faultier and a slight ache in her hands and arms on the right side and she just wondered if that was from the booster shot or might be she got something else, doing on her. The patient underwent lab test which included sugar: 110 on an unspecified date in 2021 and blood pressure: 166/90 on 02Oct2021. The action taken in response to the events for naproxen sodium (ALEVE) was unknown. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous report was received from a nurse, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of Oka-Merck PROQUAD for prophylaxis, lot #R00298 and expiration date 29-JUL-2019 (strength, dose, frequency and route of administration were not reported), that was reconstituted with a properly stored MERCK STERILE DILUENT. No adverse effects were reported. The temperature of excursion was reported as 6°F to 14°F during a time frame of 14 hours. There was no previous temperature of excursion reported. There was a digital data logger involved. This is one of several reports received from the same source. Lot number R00298 not valid for PROQUAD Oka-Merck.
Pain at site, red - itchy - hot to touch area 7" long & 3" wide started 6-13-12 - Lasted until 6-19-12 - Client used BENADRYL ice pack and a little cortisone cream.
Became fussy & had runny nose 20DEC. T @ MD office 100-101(R). On Fri night 21DEC developed a rash w/hives. 22Dec adm to hosp. Rx'd for Bronchilitis & an infection in bowel caused by Branhamella Catarrhalis generalized bacterial infect.
Entire left arm was burning, itching, and pain; Entire left arm was burning, itching, and pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Entire left arm was burning, itching, and pain) and VACCINATION SITE PAIN (Entire left arm was burning, itching, and pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20a) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Entire left arm was burning, itching, and pain) and VACCINATION SITE PAIN (Entire left arm was burning, itching, and pain). At the time of the report, VACCINATION SITE PRURITUS (Entire left arm was burning, itching, and pain) and VACCINATION SITE PAIN (Entire left arm was burning, itching, and pain) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details included Hydrocortisone cream, Antihistamine.
Menstrual cycle changed and became shorter. It became shorter from 28 days to around 21 days which has never happened in my life.
I had the injection on 03/04/2021 I had the first dose on the vaccine on 03/06/2021  four days after that I had lower pain in my back, right glute and right leg. Three more days after that on 03/13/2021  I could not get up from the couch and my right food could not raise up. I was hospitalized at the emergency department. I got there at 8 or 9 o clock at night and was hospitalized until the next day. I was there for around 5 days. It ended up being diagnosed as a infectious disease. I was on Vancomycin IV.  I was then put on vancomycin home infusion for six more weeks that along with opiates for the pain.
collagenos colitis; arm started hurting again; migraine; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COLITIS MICROSCOPIC (collagenos colitis) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   The patient's past medical history included Cancer on 20-Oct-2011 and Mastectomy bilateral on 20-Oct-2011. Concurrent medical conditions included Allergic reaction to food since January 2021, Iodine allergy since January 2021, Pain in arm (Pain returned) since January 2021, Headache aggravated (Got much worse) since January 2021 and Colitis collagenous (went away and now has returned) since January 2021. Concomitant products included CICLOSPORIN (RESTASIS) for Dry eyes, LORAZEPAM for Sleep disorder, VITAMIN D NOS for an unknown indication.  On 18-Jan-2021 at 3:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 03-Mar-2021, the patient experienced MIGRAINE (migraine). On an unknown date, the patient experienced COLITIS MICROSCOPIC (collagenos colitis) (seriousness criterion medically significant) and LIMB DISCOMFORT (arm started hurting again). At the time of the report, COLITIS MICROSCOPIC (collagenos colitis) and LIMB DISCOMFORT (arm started hurting again) outcome was unknown and MIGRAINE (migraine) had not resolved.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-075934 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a registered nurse concerning a patient who on 11-JAN-2010 and 04-FEB-2010 was vaccinated orally with doses of ROTATEQ (lot # not reported). No adverse effect was reported. Additional information has been requested.
Presumed chickenpox in vaccinated child. Rash - erythema & papular lesions on back & chest, 2 vesicular lesions. Congestion, runny nose with clear secretions. Decreased appetite & activity.
This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (having a little heart contractions), PAIN IN EXTREMITY (arm hurting), EAR PAIN (nerves on my forehead and my ears), RASH (rash on left arm) and ARTHRALGIA (shoulder really hurts) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Johnson and Johnson vaccine on 07-Apr-2021. Concurrent medical conditions included Blood pressure high and Weight increased.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced PALPITATIONS (having a little heart contractions), PAIN IN EXTREMITY (arm hurting) and ARTHRALGIA (shoulder really hurts). On 01-Dec-2021, the patient experienced EAR PAIN (nerves on my forehead and my ears), RASH (rash on left arm), NAUSEA (nausea), VOMITING (almost want to puke every time) and HEADACHE (nerves on my forehead and my ears). At the time of the report, PALPITATIONS (having a little heart contractions), PAIN IN EXTREMITY (arm hurting), EAR PAIN (nerves on my forehead and my ears), RASH (rash on left arm), ARTHRALGIA (shoulder really hurts), NAUSEA (nausea), VOMITING (almost want to puke every time) and HEADACHE (nerves on my forehead and my ears) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  Concomitant medications reported was Blood pressure medication No treatment reported.
Information has been received from a registered nurse concerning a 60 year old male patient who on 04-APR-2011 was vaccinated SQ with a 0.65ml dose of ZOSTAVAX (Merck) (lot number not provided). The nurse reported that 9 days later, on 13-APR-2011, the patient was diagnosed with shingles in the physician's office. It was unspecified if the patient was given any treatment for the adverse event, or if any lab diagnostic tests were performed. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
flu like symptoms; sneezing; coughing; nausea; vomiting; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), SNEEZING (sneezing), COUGH (coughing), NAUSEA (nausea) and VOMITING (vomiting) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and C4112DA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL (TRIBENZOR), UBIDECARENONE (COQ10 [UBIDECARENONE]) and CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), SNEEZING (sneezing), COUGH (coughing), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), SNEEZING (sneezing), COUGH (coughing), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) outcome was unknown.            patient reported having flu like symptoms 3-4mos after receiving the second dose. No Treatment medication were provided concomitant medication include symbiotic 365
The pt experienced nummular dermatitis on arms, legs and trunk since 3/00.
Severe pain in shoulder when moved. Pain while sleeping, numbness lasting to present. Saw Dr yesterday, will have physical therapy.
Ischemic stroke. Right-side insufficiency. Transported to medical center. Hospitalized for two days in stroke unit. Walking problems continue.
Received H1N1 vaccine when I was about 7 weeks pregnant.  The day I received the vaccine, I had an UltraSound and the baby was healthy with a very strong heartbeat.  I am 11 weeks pregnant, and I just had a miscarriage today 12/12/09.  I am told that the baby stopped growing at 7 weeks.  That is when I received the H1N1 vaccine.  I really do not think this vaccine is safe for pregnant woman.
A patient took Comirnaty 12+ SDV 23-2 vaccine today on Right Arm and returned to pharmacy few minutes later as he noticed discoloration (bluish-purple color skin) on the back of his palm on his right arm. Pharmacist who gave the vaccine checked the spot where it was discolored/bruised and the patient said it wasn't painful to touch, injection site was to painful to touch either, patient was able to lift his arm normally. Patient was not dizzy or had no other symptoms. Patient said he did not notice/remember having this bruise/discoloration before coming to the pharmacy, he noticed this on the back of his palm while we was shopping after getting the vaccine. Patient was asked to report at pharmacy/ get emergency help if symptoms worsens or experiences any other side effect. Patient also got RSV vaccine on Left Arm and upon checking by pharmacist everything seemed normal on left arm
Vaccine was declined by mother. Misunderstanding lead vaccine to be given. No adverse effects were noted.
mild shortness of breath; Chills; sleepiness; body aches; This is a spontaneous report from a contactable consumer. A 15-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: GW0191 and expiration date: not reported), via an unspecified route of administration on 13Jun2021 at 15:00 (at the age of 15-years-old) as dose number unknown, single for COVID-19 immunisation at pharmacy or drug store. The patient was not pregnant at the time of vaccination. The patient's medical history included hay fever and pollen allergies; from an unknown date and unknown if ongoing. Concomitant medication was not reported. No other vaccine in four weeks. On 14Jun2021, the patient experienced mild shortness of breath, chills, body aches and sleepiness. No COVID prior vaccination. No COVID tested post vaccination. No treatment received. The outcome of events was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Immediately after receiving Pfizer vaccine, pt experienced loss of consciousness for approximately 3 minutes, tongue swelling, incontinence of urine. Epi pen given x1, pt regained consciousness immediately after receiving epi. Vital signs as follows: BP 144/69, HR 63, O2 100% then approx 8 minutes later BP 113/63, HR 74, O2 99%, blood sugar 101.  Provider assessed pt and recommended to call an ambulance for possible seizure. Pt refused to go to hospital. After incident occurred, pt stated that he has had a reaction to vaccines in the past but was unsure which ones. Pt chart stated that patient had an adverse reaction  (seizure) after receiving flu, Tdap, and HPV vaccines in 2015.
Patient received her first dose of Pfizer vaccine, Lot number EW0186 at approximately 1021 AM. The patient reported feeling "numbness and tingling around my face for about ten minutes" at about 1100. Reported to Dr.  and received a verbal order for Zyrtec 10 mg. This was administer at 1103.    VS stable; 1100   139/96 100% on RA 66=Pulse 98.8 F Resp= 16   Follow up VS 1110   BP= 153/94 HR 72 O2= 100% Resp= 20   1114 Patient reported her "lips getting more swollen" She determined she would like to go to the ER to be monitored.  Lung sounds remain clear, no evidence of stridor at this time. 911 called. On their way.    Follow up VS= 1120 BP= 167/99 HR= 63 RA= 100% Resp= 20   Patient left with the ambulance at about 1130. VS remained stable. She indicated the swelling still persisted, however it was improving. Decided to go to the ER still because we do not have airways available and the patient reports not wanting to be injected with an epi-pen without cardiac monitoring.
Sore arm; This is a spontaneous report from a contactable other nurse. A 16-year-old female patient received first dose of BNT162B2 via intramuscular administered in deltoid left on an unspecified date (Batch/Lot Number and expiration date were unknown) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient just had a sore arm on an unspecified date with outcome of unknown. Reporter think the causality between event and suspect vaccine was related.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rash on face and trunk and a few spots on arms and legs for 10 days.  Much worse today-patient not sleeping well. Advised to give Benadryl every 6 hours and to follow up in 5 days if needed.
Site: Pain at Injection Site-Mild, Additional Details: Patient felt some burning at the site of injection. She reported just minutes later that it had subsided.
soreness lt deltoid since vax;devel redness on 17JAN96;also some swelling;
This spontaneous report as received from a Registered Nurse refers to patients of unknown age and gender. It was reported that on unknown dates, doses of RECOMBIVAX HB (lot number M020926, expiration date 11-AUG-2018) which were exposed to temperatures outside of the recommended range, were administered to the patients. No adverse experience had been reported. Temperature and time frame were: 1.2 degrees Celsius (C) for 22 minutes; 1.3C for 1 hour and 57 minutes; 1.4C for 2 hours and 15 minutes; 0.9C for 36 minutes; 1.3C for 21 minutes (duration: 331min). There were no previous temperature excursions. This was reported because of a data logger. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1611USA009626: US-009507513-1611USA009625: US-009507513-1611USA009623: US-009507513-1611USA008904.
p/vax pt exp high pitched cry over 3hr duration, site of inject became red & edematous, temp 102
She experienced pain in right arm where shot was administered. Also had nausea, soreness, and numbness on R side of body. She was diagnosed with Bell's Palsy and given Medrol and Valtrex.
Injection site reaction in left arm including redness, swelling 13 cm x 3 cm, warm to touch and complains of pain at injection site.  Also complains of chills and fever after receiving vaccinations.
severe headache, red line at the site of the injection going to the underarm, swelling of lymph nodes on left side of body ( under arm, clavidle). severe pain under arm. these symptoms are still present 3 days later and not any better.
This spontaneous report as received from an unspecified reporter refers to patient of unknown age and gender. The patient's relevant medical history was not reported. On 11-NOV-2014, the patient was vaccinated with a dose of MMR II (therapy type, route, dose, frequency and lot # were not reported) which underwent an excursion. This is one of several reports received from the same source. Additional information has been requested.
This retrospective study aimed to assess the prevalence of non-immunity to varicella zoster virus (VZV) and measles in previously immunized pediatric liver transplant (LT) recipients and identify correlative factors. Children who received LT were evaluated for pre-LT immunization and post-LT VZV and measles titers during clinic visits from January 2016 to November 2017. Those who did not receive VZV or measles vaccine prior to LT were excluded from the respective cohort. 72 patients were included in the analysis of measles immunity, and 67 in the analysis of VZV immunity. Median time from LT to titers for measles and VZV were 4.0  and 3.2 (0.8-14.0) years, respectively. In the measles cohort, the median age at LT was 3.2 (0.7-16.2) years. Age at LT, age at last pre-LT vaccine dose, number of pre-LT vaccine doses, height and use of whole-liver grafts were each significantly lower for non-immune versus immune patients, and the proportion of patients of ethnicity was greater in the non-immune group. It was concluded that non-immunity to measles and VZV among pediatric LT recipients was common within 3 years after liver transplantation, despite immunization prior to transplant. This literature marketed report as received from the authors of the published literature article, refers to 42 children of unknown ages and genders. The patients' concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients vaccinated with varicella virus vaccine live (manufacture unknown) (dose, route, lot# and expiration were not reported) for prophylaxis. On unknown dates, at the post-transplant follow up point, the patients were VZV non-immune (therapy non-responder). The outcome of the event was not reported. The reporter considered the event to be related to varicella virus vaccine live (manufacture unknown). This is one of several reports received from the same literature.; Sender's Comments: US-009507513-1811USA006964:
Fever 102.6; Nausea; Vomiting; Body aches; Headache; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0170) via an unspecified route of administration in the right arm on 21Apr2021 at 14:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other unspecified vaccine within four weeks prior to the vaccination on 01Apr2021. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 04:30, the patient experienced fever 102.6, nausea, vomiting, body aches, headache and feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever 102.6, nausea, vomiting, body aches, headache and feeling unwell were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.